CoChat

Accelerated evolution of resistance in multidrug environments

Open access
Hegreness, Matthew, Shoresh, Noam, Damian, Doris, Hartl, Daniel, Kishony, Roy · 2008 · Proceedings of the National Academy of Sciences

The DOI matches its Crossref record; 32 of the 33 references it cites were found in a registry or an index.

Abstract

The emergence of resistance during multidrug chemotherapy impedes the treatment of many human diseases, including malaria, TB, HIV, and cancer. Although certain combination therapies have long been known to be more effective in curing patients than single drugs, the impact of such treatments on the evolution of drug resistance is unclear. In particular, very little is known about how the evolution of resistance is affected by the nature of the interactions—synergy or antagonism—between drugs. Here we directly measure the effect of various inhibitory and subinhibitory drug combinations on the rate of adaptation. We develop an automated assay for monitoring the parallel evolution of hundreds of Escherchia coli populations in a two-dimensional grid of drug gradients over many generations. We find a correlation between synergy and the rate of adaptation, whereby evolution in more synergistic drug combinations, typically preferred in clinical settings, is faster than evolution in antagonistic combinations. We also find that resistance to some synergistic combinations evolves faster than resistance to individual drugs. The accelerated evolution may be due to a larger selective advantage for resistance mutations in synergistic treatments. We describe a simple geometric model in which mutations conferring resistance to one drug of a synergistic pair prevent not only the inhibitory effect of that drug but also its enhancing effect on the other drug. Future study of the profound impact that synergy and other drug-pair properties can have on the rate of adaptation may suggest new treatment strategies for combating the spread of antibiotic resistance.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0805965105

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 1

  1. 10.1016/s1473-3099(05)70086-4 · doi:10.1016/s1473-3099(05)70086-4 · Paper page

Cited by

See all 341

Metadata

Authors
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R.
Affiliations
  • Harvard University (US)
  • *Department of Systems Biology, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115;
  • Vertex Pharmaceuticals (United States) (US)
  • Department of Organismic and Evolutionary Biology and
Venue
Proceedings of the National Academy of Sciences
Published
2008-09-16
Volume
105
Issue
37
Pages
13977-13981
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2080777238
Cited by
300
References
33
Citations by year
2026: 8 · 2025: 17 · 2024: 23 · 2023: 26 · 2022: 12 · 2021: 21 · 2020: 18 · 2019: 20 · 2018: 12 · 2017: 28 · 2016: 18 · 2015: 21 · 2014: 18 · 2013: 21 · 2012: 7
FWCI
5.70
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Institutes of Health
  • National Institute of General Medical Sciences (R01GM081617)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
  • Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
Keywords
drug resistance evolution, multidrug chemotherapy, drug synergy, drug antagonism, combination therapy, rate of adaptation, Escherichia coli, parallel evolution, antibiotic resistance, resistance mutations
MeSH terms
Adaptation, Biological, Biological Evolution, Drug Resistance, Multiple

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.